Recommend to a Friend
  Send Mail   Cancel
Sender Name:
Title: FDA Allows Clinical Studies of Tysabri (natalizumab) for Treatment of MS to Proceed
Url: http://www.fda.gov/bbs/topics/news/2006/NEW01319.html
Mail Address:
[ Back ]
Robyne Wilkerson
Our other Physiatry Related Sites by PM&R Resources R. Wilkerson